(2S)-2-[[4-[[(6S)-2-amino-5-formyl-4-oxo-1,6,7,8-tetrahydropteridin-6- yl]methylamino]benzoyl]amino]pentanedioic acid
Modify Date: 2024-01-06 00:29:49
![(2S)-2-[[4-[[(6S)-2-amino-5-formyl-4-oxo-1,6,7,8-tetrahydropteridin-6- yl]methylamino]benzoyl]amino]pentanedioic acid Structure](https://image.chemsrc.com/caspic/087/68538-85-2.png)
(2S)-2-[[4-[[(6S)-2-amino-5-formyl-4-oxo-1,6,7,8-tetrahydropteridin-6- yl]methylamino]benzoyl]amino]pentanedioic acid structure
|
Common Name | (2S)-2-[[4-[[(6S)-2-amino-5-formyl-4-oxo-1,6,7,8-tetrahydropteridin-6- yl]methylamino]benzoyl]amino]pentanedioic acid | ||
|---|---|---|---|---|
| CAS Number | 68538-85-2 | Molecular Weight | 473.43900 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C20H23N7O7 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of (2S)-2-[[4-[[(6S)-2-amino-5-formyl-4-oxo-1,6,7,8-tetrahydropteridin-6- yl]methylamino]benzoyl]amino]pentanedioic acidLevoleucovorin (Levofolinic acid) is the pharmacologically active levoisomer of racemic leucovorin. Levoleucovorin can be used as a rescue agent after high-dose Methotrexate (HY-14519) therapy, and in combination with fluorouracil for the research of advanced metastatic colorectal cancer[1]. |
| Name | (6S)-5-formyltetrahydrofolic acid |
|---|
| Description | Levoleucovorin (Levofolinic acid) is the pharmacologically active levoisomer of racemic leucovorin. Levoleucovorin can be used as a rescue agent after high-dose Methotrexate (HY-14519) therapy, and in combination with fluorouracil for the research of advanced metastatic colorectal cancer[1]. |
|---|---|
| Related Catalog | |
| Target |
Human Endogenous Metabolite |
| References |
| Molecular Formula | C20H23N7O7 |
|---|---|
| Molecular Weight | 473.43900 |
| Exact Mass | 473.16600 |
| PSA | 219.84000 |
| LogP | 1.15290 |